FIELD: medicine, allergology. SUBSTANCE: drops has cromolyn sodium or nedocromyl sodium or cromoglycic acid, dexamethasone-21-phosphate sodium salt, sterile buffer solution and, if necessary, ephedrine hydrochloride. Other variant of the proposed drops involves cromolyn sodium or nedocromyl sodium or cromoglycic acid, dimedrol, buffer solution and, if necessary, dexamethasone- -21-phosphate sodium salt and ephedrine hydrochloride. An additional variant of drops involves cromolyn sodium or nedocromyl sodium or cromoglycic acid and ephedrine hydrochloride in buffer solution. Drops are used by 1-2 drops into both nostrils and/or in both eyes, 4-5 times per a day. EFFECT: enhanced effectiveness, decreased adverse effects. 7 cl, 1 ex
